121 related articles for article (PubMed ID: 3962450)
1. Effect of low level immunity on response to live rubella virus vaccine.
Väänänen P; Mäkelä P; Vaheri A
Vaccine; 1986 Mar; 4(1):5-8. PubMed ID: 3962450
[TBL] [Abstract][Full Text] [Related]
2. Persistence of antibody induced by rubella vaccine (Wistar RA 27/3 strain) after six years.
Hillary IB; Freestone DS
J Hyg (Lond); 1975 Dec; 75(3):407-11. PubMed ID: 1059708
[TBL] [Abstract][Full Text] [Related]
3. Are many women immunized against rubella unnecessarily?
Mortimer PP; Edwards JM; Porter AD; Tedder RS; Mace JE; Hutchinson A
J Hyg (Lond); 1981 Aug; 87(1):131-8. PubMed ID: 7019319
[TBL] [Abstract][Full Text] [Related]
4. The immunoglobulin M response to rubella vaccine in young adult women.
Mortimer PP; Edwards JM; Porter AD; Tedder RS; Haslehurst J
J Hyg (Lond); 1984 Jun; 92(3):277-83. PubMed ID: 6376624
[TBL] [Abstract][Full Text] [Related]
5. [Seroimmunity against rubella 5 years after immunisation with Cendehill vaccine (author's transl)].
Sarateanu DE; Ehrengut W
Immun Infekt; 1975 Apr; 3(2):51-3. PubMed ID: 1184096
[TBL] [Abstract][Full Text] [Related]
6. Susceptibility to rubella and borderline immunity.
Fogel A; Barnea B; Gerichter CB
Isr J Med Sci; 1983 Oct; 19(10):934-5. PubMed ID: 6363349
[TBL] [Abstract][Full Text] [Related]
7. Duration of immunity after rubella vaccination: a long-term study in Switzerland.
Just M; Just V; Berger R; Burkhardt F; Schilt U
Rev Infect Dis; 1985; 7 Suppl 1():S91-4. PubMed ID: 4001742
[TBL] [Abstract][Full Text] [Related]
8. Persistence of antibody titers after vaccination with rubella virus vaccine ("Cendehill" strain).
Peetermans J; du Pan RM; Huygelen C
Dev Biol Stand; 1979; 43():361-5. PubMed ID: 520683
[TBL] [Abstract][Full Text] [Related]
9. Rubella vaccination: persistence of antibodies for up to 16 years.
O'Shea S; Best JM; Banatvala JE; Marshall WC; Dudgeon JA
Br Med J (Clin Res Ed); 1982 Jul; 285(6337):253-5. PubMed ID: 6807437
[TBL] [Abstract][Full Text] [Related]
10. Rubella antibody titres and immunization status in a family practice.
Mills DA; Parker KR; Evans CE
Can Med Assoc J; 1980 Mar; 122(5):549-52. PubMed ID: 7370858
[TBL] [Abstract][Full Text] [Related]
11. Rubella immune state and rubella vaccination of female university students.
Nyström M; Peräsalo J
Scand J Infect Dis; 1984; 16(3):235-9. PubMed ID: 6494810
[TBL] [Abstract][Full Text] [Related]
12. [Reasons for repeated serologically unsuccessful (HAI-HIG test) rubella vaccination (author's transl)].
Ehrengut W; Florent G
Dtsch Med Wochenschr; 1981 Jul; 106(31-32):987-9. PubMed ID: 7261921
[TBL] [Abstract][Full Text] [Related]
13. Studies on the reactogenicity and immunogenicity of the BRD-2 and RA27/3 live attenuated rubella vaccines.
Wang SS; Han YR; Su WN; Chen J; Zhao K
Vaccine; 1984 Dec; 2(4):277-80. PubMed ID: 6531968
[TBL] [Abstract][Full Text] [Related]
14. Challenge with rubella virus after loss of detectable vaccine-induced antibody.
Schiff GM; Young BC; Stefanovic' GM; Stamler EF; Knowlton DR; Grundy BJ; Dorsett PH
Rev Infect Dis; 1985; 7 Suppl 1():S157-63. PubMed ID: 4001723
[TBL] [Abstract][Full Text] [Related]
15. Rubella in Orkney: seroepidemiology and vaccination.
Moffat MA; Heywood SN; Laughton E; Gould JJ; Freestone DS
J Hyg (Lond); 1977 Jun; 78(3):419-27. PubMed ID: 266542
[TBL] [Abstract][Full Text] [Related]
16. Antibody titres in women six to eight years after the administration of RA2713 and Cendehill rubella vaccines.
Macdonald H; Tobin JO; Cradock-Watson JE; Lomax J
J Hyg (Lond); 1978 Jun; 80(3):337-47. PubMed ID: 649946
[TBL] [Abstract][Full Text] [Related]
17. Use of the direct haemolysis-in-gel test for rubella antibodies in the Icelandic prevention programme for congenital rubella.
Einarsdóttir B; Bjarnadóttir K
J Clin Pathol; 1983 Nov; 36(11):1253-5. PubMed ID: 6355196
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a two-dose measles, mumps, and rubella vaccination schedule in a cohort of college athletes.
Coté TR; Sivertson D; Horan JM; Lindegren ML; Dwyer DM
Public Health Rep; 1993; 108(4):431-5. PubMed ID: 8341775
[TBL] [Abstract][Full Text] [Related]
19. Vaccination with a live RA 27/3 strain rubella vaccine (Rudivax), a follow-up study.
Suni JI; Meurman O; Hirvonen P; Vaheri A
Vaccine; 1984 Dec; 2(4):281-3. PubMed ID: 6531969
[TBL] [Abstract][Full Text] [Related]
20. Development of immunoglobulin M-antibodies after rubella immunization with RA27/3 attenuated live vaccine in teen-agers: remaining problems.
Braito A; Fanti O; Rossolini GM; Cellesi C
Boll Ist Sieroter Milan; 1991-1992; 70(1-2):443-8. PubMed ID: 1670047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
